Cryotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The cryotherapy market size is expected to increase from USD 322.04 million in 2025 to USD 339.94 million in 2026 and reach USD 464.61 million by 2031, growing at a CAGR of 6.45% over 2026-2031. This report is Segmented by Product and Services (Whole-Body Cryochambers, Localised Devices, Cryosurgery Systems, Hybrid/Mobile Units, and More), Application (Sports Recovery, and More), End User (Hospitals & Specialty Clinics, and More), Technology (Liquid-Nitrogen Systems and More), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Cryotherapy Market Trends and Insights

Rapid Shift From Liquid-Nitrogen to Fully-Electric Cryo-Systems Cut Costs

Clinics switching to electric chambers remove weekly dewar deliveries, lower insurance premiums linked to pressurized-gas storage, and meet net-zero mandates in the European Union and California. CryoBuilt’s Polaris electric chamber demonstrated a 60% reduction in five-year operating cost compared with nitrogen models. The transition accelerates in regions with unstable gas logistics, enabling new operators in Southeast Asia and Latin America to enter the cryotherapy market without specialized supply chains. Facility managers also favor electric units because they bypass OSHA oxygen-monitor requirements. Collectively, these shifts add 1.2 percentage points to forecast CAGR by broadening the serviceable venue base and raising replacement demand.

Reimbursement Expansion in Key Regions

The American Medical Association introduced CPT 64624 in 2024, legitimizing cryoneurolysis billing and prompting capital purchases in pain clinics. Germany’s insurers began reimbursing whole-body cryotherapy for rheumatoid arthritis under pilot programs in 2025, signaling a European precedent. Although the U.S. Centers for Medicare & Medicaid Services still classifies whole-body cryo as investigational, partial reimbursement steers investment toward localized medical devices that enjoy procedural fees. Over the long term, consistent payer recognition could inject nearly 1 percentage point into the global CAGR, especially if more Payors align on chronic-pain indications.

Rising Gas Prices Increase Risks

European nitrogen spot prices spiked above EUR 50 per MWh in late 2025, eroding margins at high-volume sports clinics and prompting deferred purchases of nitrogen-fed systems. Operators recalculated break-even analyses, delaying replacement cycles until electric alternatives become affordable. Similar volatility in Asia-Pacific LNG markets compresses budgets in Japan and South Korea. These conditions shave 0.8 percentage points off short-term growth.

Other drivers and restraints analyzed in the detailed report include:

• Increased Cryo Access in Fitness Clubs
• AI-Driven Chambers Enhance Throughput
• Insurer Pushback Due to Lack of Standards Benchmarking Study

Segment Analysis

Whole-body cryochambers generated almost half of 2025 revenue, yet hybrid and mobile units will outpace at a 10.63% CAGR as rental operators send trailer-mounted systems to events and corporate campuses. The shift diversifies the cryotherapy market because customers with no capital budget can still provision sessions on demand.

Consumables revenue shrinks as the sector turns electric, but software subscriptions grow when operators use cloud dashboards to schedule sessions, track utilization, and document safety compliance. Localized devices hold roughly 18% share, driven by dermatology uptake for aesthetic spot treatments. Cryosurgery systems, vested mainly in oncology, maintain steady adoption inside interventional radiology suites. Accessories, including nitrogen dewars and thermal gloves, taper in lock-step with the electric transition, so vendors hedge by bundling maintenance contracts and analytics platforms. The evolving mix means chamber form-factors, not temperatures, define competitive advantage, intensifying a platform race across the cryotherapy market.

Sports recovery retained 33.45% of the cryotherapy market size in 2025 thanks to elite teams and collegiate programs. Dermatology and aesthetics, however, add sessions faster, climbing 9.24% annually through 2031 on social-media visibility and financing plans.

Pain-management clinics deploy cryoneurolysis probes under CPT 64624, but reimbursement gaps cap statewide rollouts. Oncology usage broadens as imaging-guided cryoablation lowers collateral tissue damage, supporting steady unit placements inside tertiary hospitals. Wellness and weight-management kiosks remain fragmented yet visible in luxury resorts that position cryo as a metabolism booster. The application landscape shows recovery saturation in professional sports, so operators court amateur athletes, beauty seekers, and chronic-pain patients to enlarge the cryotherapy market.

Complete Report Scope:

• By Product and Services
  • Whole-Body Cryochambers
  • Localised Devices
  • Cryosurgery Systems
  • Hybrid / Mobile Units
  • Accessories and Conusmables
  • Software and Services
• By Application
  • Sports Recovery
  • Pain Management
  • Oncology (Cryo-ablation)
  • Dermatology & Aesthetics
  • Wellness & Weight-Management
• By End User
  • Hospitals & Specialty Clinics
  • Sports & Fitness Centers
  • Wellness & Spa Facilities
  • Home-Use / Direct-to-Consumer
• By Technology
  • Liquid-Nitrogen Systems
  • Fully-Electric Systems
  • CO₂ Spot-Therapy Devices
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America generated 37.83% of global revenue in 2025, with the United States comprising 85% of that figure on the back of pro-sports demand and early medical reimbursement. Canada and Mexico remain smaller but stable, supporting cash-pay models in Toronto, Vancouver, Monterrey, and Mexico City. FDA clearance of IceCure’s ProSense system for benign breast tumors signals regulatory momentum for minimally invasive cryoablation.

Asia-Pacific will expand the cryotherapy market at 7.74% through 2031 as China’s domestic builders undercut European imports by 30-40%. Japan rides aging-population demand for non-pharmacological pain relief despite absent reimbursement. India’s cricket academies and private hospitals in Mumbai and Bangalore buy chambers to serve professional and affluent amateur athletes. South Korea gravitates toward aesthetics in Seoul’s Gangnam district, while Australia focuses on sports recovery in Sydney and Melbourne. Fragmented rules and cultural preferences for traditional remedies slow uptake, but growing middle-class income and sports participation widen the user base.

In Europe, Germany led, aided by statutory insurers piloting cryo coverage for rheumatoid arthritis. France’s thalassotherapy spas and the United Kingdom’s Premier League clinics maintain robust demand. Italy and Spain add aesthetic and sports-rehab users respectively. Middle East and Africa collectively held about 6% share, dominated by UAE and Saudi Arabia luxury wellness centers. South America’s 5% share is concentrated in Brazil and Argentina, where private hospitals equip orthopedic wards. Together, these regional profiles underline differing adoption curves yet a converging preference for electric, data-rich hardware across the cryotherapy market.

List of Companies Covered in this Report:

• Art of Cryo
• Boston Scientific
• Brymill Cryogenic Systems
• The Cooper Companies
• Cryo Innovations
• CRYO Science
• CryoAction
• CryoBuilt Inc.
• Cryomed s.r.o.
• CRYONiQ
• Grand Cryo
• IceCure Medical
• Impact Cryotherapy Inc.
• JUKA
• KRION
• MECOTEC GmbH
• Medtronic plc (Cryoablation)
• Metrum CryoFlex
• Vacuactivus
• Zimmer MedizinSysteme

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support